Altered Plasma MicroRNA Expression in Patients with Mitral Chordae Tendineae Rupture

Mehmet Bulent Vatan1, Aysel Kalaycı Yigin2, Ramazan Akdemir3

  • 1Department of Cardiology, Sakarya University School of Medicine, Sakarya, Turkey. Electronic correspondence: bulentvatan@hotmail.com.

Abstract

Insights

This study found that 22 specific microRNAs (miRNAs) are down-regulated in patients with mitral chordae tendineae rupture (MCTR). These miRNAs are involved in pathways crucial for MCTR development, offering new insights into this severe heart condition.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Mitral chordae tendineae rupture (MCTR) is a progressive disorder causing severe mitral regurgitation.
  • The exact pathogenetic mechanisms underlying MCTR remain largely unknown.
  • Investigating circulating microRNAs (miRNAs) offers a potential avenue to understand MCTR development.

Purpose of the Study:

  • To investigate the expression profile of circulating miRNAs in patients with primary MCTR.
  • To identify specific miRNAs potentially involved in the pathogenesis of MCTR.
  • To explore the target genes and pathways associated with differentially expressed miRNAs in MCTR.

Main Methods:

  • A case-control study involving 21 patients with primary MCTR and 30 matched controls.
  • Comparison of circulating miRNA expression levels between MCTR patients and controls.
  • Bioinformatic analysis using four target gene databases to predict miRNA targets and pathways.

Main Results:

  • Twenty-two specific miRNAs were significantly down-regulated in MCTR patients compared to controls.
  • Key miRNAs identified include miR-106b-5p, miR-126-3p, miR-150-5p, and others.
  • Bioinformatic analysis predicted that MMPs, TIMP-2, TGFBR2, VEGFA, and other genes/pathways are targeted by these miRNAs.

Conclusions:

  • This study is the first to report altered miRNA expression in MCTR patients.
  • Circulating miRNAs play a regulatory role in the development of MCTR.
  • The findings provide a foundation for understanding MCTR pathogenesis and potential therapeutic targets.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
798
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
786
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.0K
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
666
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
469
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
445